Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hull

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Journal of Medical Internet Research|July 24, 2019
The PrEP You Want: A Web-Based Survey of Online Cross-Border Shopping for HIV Prophylaxis MedicationsBen Walmsley, Dan Gallant, Mark Naccarato, et al.
Sexual Health|May 2, 2019
Community awareness of, use of and attitudes towards HIV pre-exposure prophylaxis (PrEP) among men who have sex with men in Vancouver, Canada: preparing health promotion for a publicly funded PrEP programNathan J Lachowsky, Tessa Lawson Tattersall, Paul Sereda, et al.
Eclinicalmedicine|September 29, 2025
Diagnostic performance of HIV risk assessment tools for identifying pre-exposure prophylaxis candidates: a systematic review and meta-analysisMyo Minn Oo, Monica Rudd, Caley Shukalek, et al.
Chest|February 6, 2013
Epidemic of lung cancer in patients with HIV infectionTiffany A Winstone, S F Paul Man, Mark Hull, et al.
Journal of the International AIDS Society|August 9, 2016
Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settingsViviane D Lima, Mark Hull, David McVea, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|February 4, 2014
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adultsMark Hull, Marina Klein, Stephen Shafran, et al.
Antiviral Therapy|December 6, 2012
Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individualsMarina B Klein, Kathleen C Rollet, Mark Hull, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|March 18, 2014
[Not Available]Mark Hull, Pierre Giguère, Marina Klein, et al.
BMJ Open Gastroenterology|May 20, 2021
Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopySara Koo, Linda Sharp, Mark Hull, et al.
Sexual Health|May 31, 2023
Gay, bisexual, and queer men's confidence in the Undetectable equals Untransmittable HIV prevention message: longitudinal qualitative analysis of the sexual decision-making of pre-exposure prophylaxis users over timeDaniel Grace, Emerich Daroya, Mark Gaspar, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Journal of Medical Internet Research|July 24, 2019
The PrEP You Want: A Web-Based Survey of Online Cross-Border Shopping for HIV Prophylaxis MedicationsBen Walmsley, Dan Gallant, Mark Naccarato, et al.
Sexual Health|May 2, 2019
Community awareness of, use of and attitudes towards HIV pre-exposure prophylaxis (PrEP) among men who have sex with men in Vancouver, Canada: preparing health promotion for a publicly funded PrEP programNathan J Lachowsky, Tessa Lawson Tattersall, Paul Sereda, et al.
Eclinicalmedicine|September 29, 2025
Diagnostic performance of HIV risk assessment tools for identifying pre-exposure prophylaxis candidates: a systematic review and meta-analysisMyo Minn Oo, Monica Rudd, Caley Shukalek, et al.
Chest|February 6, 2013
Epidemic of lung cancer in patients with HIV infectionTiffany A Winstone, S F Paul Man, Mark Hull, et al.
Journal of the International AIDS Society|August 9, 2016
Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settingsViviane D Lima, Mark Hull, David McVea, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|February 4, 2014
CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adultsMark Hull, Marina Klein, Stephen Shafran, et al.
Antiviral Therapy|December 6, 2012
Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individualsMarina B Klein, Kathleen C Rollet, Mark Hull, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|March 18, 2014
[Not Available]Mark Hull, Pierre Giguère, Marina Klein, et al.
BMJ Open Gastroenterology|May 20, 2021
Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopySara Koo, Linda Sharp, Mark Hull, et al.
Sexual Health|May 31, 2023
Gay, bisexual, and queer men's confidence in the Undetectable equals Untransmittable HIV prevention message: longitudinal qualitative analysis of the sexual decision-making of pre-exposure prophylaxis users over timeDaniel Grace, Emerich Daroya, Mark Gaspar, et al.
Pageof 13